Bupivacaine Hcl Injection, Solution
Product Images NDC 51662-1592

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hcl (NDC 51662-1592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Boxed Warning (Boxed Warning)

This text panel provides detailed warnings and precautions regarding the use of 0.75% concentration Sensorcaine injection and bupivacaine HCl in regional anesthesia. It discusses risks such as cardiac arrest, toxicity, contraindications for certain patients, and guidelines for administration and monitoring in various clinical scenarios, including obstetrical anesthesia, chondrolysis, and pediatric use.*

FDA Label Image

Case Labeling (Case A)

Label for SENSORCAINE (BUPIVACAINE HCl) Injection, USP, 0.25% (2.5 mg/mL) strength in a 50 mL vial, packaged as a case of 25. It includes lot number, expiration date, NDC 51662-1592-3, manufacturer HF Acquisition Co LLC, and directions specifying use for infiltration and nerve block only, not for caudal, epidural, or spinal anesthesia.*

FDA Label Image

Dosage (Dosage)

A table titled 'Recommended Concentrations and Doses of Sensorcaine (bupivacaine HCl) Injections' displaying types of nerve blocks, concentrations, volume in milliliters, dose in milligrams, and degree of motor block for various administration routes including local infiltration, epidural, caudal, peripheral nerves, retrobulbar, sympathetic, dental, and epidural injections. The table includes footnotes explaining dosing considerations for motor block effects and repeat doses.*

FDA Label Image

Logo (Logo)

FDA Label Image

Pouch Labeling (Pouch 1)

Label for SENSORCAINE (BUPIVACAINE HCl Injection) USP 0.5% 250 mg/50 mL (5 mg/mL) solution in a 50 mL vial. Manufactured by HF Acquisition Co., LLC, Mukilteo, WA. The label includes NDC 51662-1588-2, lot number, expiration date, and usage instructions indicating it is for nerve block only, not for caudal, epidural, or spinal anesthesia.*

FDA Label Image

Pouch Labeling (Pouch A)

BUPIVACAINE HCl Injection, USP vial label showing 2.5 mg/mL strength with 125 mg total per 50 mL vial. The label includes NDC 51662-1592-2, lot number, expiration date, inactive ingredients, and usage instructions specifying infiltration and nerve block only. Manufactured by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA.*

FDA Label Image

Precaution (Precaution)

A data table titled 'Examples of Drugs Associated with Methemoglobinemia' listing drug classes including Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with specific drug examples given under each category.*

FDA Label Image

Rfid Labeling (Rfid A)

BUPIVACAINE HCl injection solution packaging label displaying the HF Acquisition Co LLC, DBA HealthFirst as the labeler. The label includes a QR code and batch information but does not specify strength or package size visible in the image.*

FDA Label Image

Vial Label (Sensorcaine Vial Label)

Label for Sensorcaine (Bupivacaine HCl) Injection, USP, 0.5% (5 mg/mL) strength. The vial contains 50 mL (250 mg) of solution, indicated for nerve block only. It is a multiple dose vial and labeled Rx only. The NDC is 63323-467-01.*

FDA Label Image

Case Labeling (Sensorcaine Case Label)

Packaging label for SENSORCAINE (BUPIVACAINE HCl) Injection, USP 0.5%, containing 250 mg per 50 mL vial (5 mg/mL). The label indicates a 50 mL vial with a case of 25, manufactured by HF Acquisition Co LLC, DBA HealthFirst in Mukilteo, WA. The label includes lot number, expiration date, and storage instructions for the injection solution.*

FDA Label Image

S1 (Structure 1)

Chemical structure diagram of BUPIVACAINE HCl, showing the molecular configuration including the piperidine ring, amide linkage to a substituted aromatic ring, and associated hydrochloride and water molecules.*

FDA Label Image

S2 (Structure 2)

Chemical structure diagram of the active ingredient BUPIVACAINE HCl, showing its molecular composition and bonding arrangement.*

FDA Label Image

Vial Labeling (Vial A)

Label of Sensorcaine (Bupivacaine HCl Injection, USP) 0.25%, with a strength of 125 mg per 50 mL (2.5 mg/mL), in a 50 mL multiple dose vial. It indicates use for infiltration and nerve block only, with a warning against caudal, epidural, or spinal anesthesia. Rx only, labeled by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Warning (Waarnings)

This image shows a drug safety and usage information panel for Bupivacaine HCl injection. The text details warnings about the 0.75% concentration not recommended for obstetrical anesthesia due to cardiac risks, guidelines for clinicians on management of toxic reactions, cautions about use with local anesthetics containing preservatives, and contraindications with certain drugs and patient populations. It also addresses post-marketing reports, administration precautions, and recommendations against mixing with other anesthetics.*

FDA Label Image

Indication (Indication 1)

A table listing various clinical uses with corresponding concentration percentages of Bupivacaine HCl injection solution. It includes uses such as local infiltration (0.25%), peripheral nerve block (0.25% and 0.5%), retrobulbar block (0.75%), sympathetic block (0.25%), lumbar epidural (0.25%, 0.5%, and 0.75%), caudal (0.25% and 0.5%), epidural test dose (0.5% with epinephrine 1:200,000), and dental blocks (0.5% with epinephrine 1:200,000).*

FDA Label Image

Rfid Labeling (Rfid 1)

A portion of the packaging label for BUPIVACAINE HCl injection, solution, showing several GS1 identification codes and a DataMatrix barcode. The label includes the text advising to see the manufacturer's package insert and indicates the product is distributed by HF Acquisition Co., LLC in Mukilteo, WA. The label also notes RX ONLY.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.